MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$644,371K
EPS
-$3.06
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
-
-
0*
-
Research and development
394,919
343,970
199,814*
262,506
General and administrative
110,213
101,252
36,748*
52,763
Total operating expenses
505,132
445,222
236,562*
315,269
Loss from operations
-505,132
-445,222
-236,562*
-315,269
Interest income
35,579
19,508
24,445*
22,083
Interest expense
23,781
12,197
-10,053*
11,428
Change in fair value of warrant liability and contingent earn-out shares
-
-
-13,582*
-592
Change in fair value of warrant liability
151,031
15,788
-
-
Other expense, net
-6
117
37*
0
Total non-operating income (expense), net
-139,239
-8,594
20,879*
10,063
Loss before income taxes
-644,371
-453,816
-215,683*
-305,206
Benefit from income taxes
-
-
0*
-
Net loss
-644,371
-453,816
-215,683*
-305,206
Unrealized loss on investments, net
-
-
-3,526*
1,814
Comprehensive loss
-
-
-219,209
-303,392
Basic EPS
-3.06
-2.29
-1.148
-1.61
Diluted EPS
-3.06
-2.29
-1.148
-1.61
Basic Average Shares
210,893,604
198,098,047
191,026,746
189,231,562
Diluted Average Shares
210,893,604
198,098,047
191,026,746
189,231,562
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$644,371K
Loss before income
taxes
-$644,371K
Loss from operations
-$505,132K
Total non-operating
income (expense), net
-$139,239K
Interest income
$35,579K
Total operating
expenses
$505,132K
Change in fair value of
warrant liability
$151,031K
Interest expense
$23,781K
Other expense, net
-$6K
Research and development
$394,919K
General and
administrative
$110,213K
Buy us a coffee
Revolution Medicines, Inc. (RVMDW)
Revolution Medicines, Inc. (RVMDW)